Passed Senate, under the order of 1/30/2026, having achieved 60 votes in the affirmative, with amendments by Yea-Nay Vote. 71 - 29. Record Vote Number: 20.
The Consolidated Appropriations Act, 2026 is a large omnibus spending bill that funds federal agencies for FY2026 and includes multiple appropriations divisions (Defense; Labor/HHS/Education; Transportation/HUD; Financial Services; State/Foreign Operations; and others), policy riders, procurement authorities, domestic sourcing requirements, foreign security assistance authorities and reporting requirements, health care-related reforms (including pharmacy benefit manager rebate remittance and generic drug transparency), and various program-specific directives and restrictions.
Progressive objects to large defense spending while praising PBM and drug transparency
Relative to its intended legislative type (a consolidated appropriations Act), this bill is well-constructed: it provides detailed appropriations by account and program, integrates with existing statutes, and embeds multiple execution, oversight, and anti-abuse provisions.
The Consolidated Appropriations Act, 2026 is a large omnibus spending bill that funds federal agencies for FY2026 and includes multiple appropriations divisions (Defense; Labor/HHS/Education; Transportation/HUD; Financial Services; State/Foreign Operations; and others), policy riders, procurement authorities, domestic sourcing requirements, foreign security assistance authorities and reporting requirements, health care-related reforms (including pharmacy benefit manager rebate remittance and generic drug transparency), and various program-specific directives and restrictions.
Must‑fund nature, broad inclusion of constituent and programmatic items, and extensive compromise language raise likelihood despite fiscal size and some contested riders.
Relative to its intended legislative type (a consolidated appropriations Act), this bill is well-constructed: it provides detailed appropriations by account and program, integrates with existing statutes, and embeds multiple execution, oversight, and anti-abuse provisions. It also contains substantive statutory amendments and programmatic provisions beyond pure funding.
Progressive objects to large defense spending while praising PBM and drug transparency
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressive objects to large defense spending while praising PBM and drug transparency
This persona sees the bill as a mixed outcome.
They welcome health-care provisions that increase drug-market transparency and curb PBM rebate retention, but criticize very large defense and procurement appropriations and limited climate or social investment priorities in the text provided.
A pragmatic centrists view the bill as necessary annual governance: it funds core national defense and domestic programs while adding operational oversight and targeted reforms.
They weigh structural improvements and transparency against the bill’s size and the political tradeoffs required to pass an omnibus.
This persona generally approves: the bill funds robust defense capabilities, supports domestic industry via Buy American and steel/ball-bearing rules, preserves procurement and shipbuilding in U.S. yards, and contains authorities needed for security assistance.
They view some healthcare market rules as regulatory overreach but not deal-breaking.
Reached or meaningfully advanced
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Must‑fund nature, broad inclusion of constituent and programmatic items, and extensive compromise language raise likelihood despite fiscal size and some contested riders.
The House accepted the Senate's changes. Both chambers now agree — the bill heads to the President.
The Senate passed this bill. It now goes to the other chamber, and eventually to the President for signature.
The final vote on whether the bill becomes law (pending the other chamber and the President).
This amendment was rejected and will not be included in the bill.
Progressive objects to large defense spending while praising PBM and drug transparency
Must‑fund nature, broad inclusion of constituent and programmatic items, and extensive compromise language raise likelihood despite fiscal…
Relative to its intended legislative type (a consolidated appropriations Act), this bill is well-constructed: it provides detailed appropriations by account and program, integrates with existing statutes, and embeds mul…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.